Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.50 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 8/20 | 0.36 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21116259 | 0.94 | KIF11 (0.45) | KIF11TRPV4ARPGRPDPK1 | |
| SCHEMBL21116475 | 0.93 | KIF11 (0.56) | KIF11TRPV4ARPGRPDPK1 | |
| SCHEMBL21116910 | 0.89 | KIF11 (0.44) | KIF11ARPGRHDAC1HDAC6 | |
| SCHEMBL21116534 | 0.89 | KIF11 (0.50) | KIF11TRPV4ARPGRCYP11B2 | |
| SCHEMBL21116564 | 0.88 | KIF11 (0.42) | KIF11TRPV4ARPGRKDM1A | |
| SCHEMBL21116487 | 0.87 | KIF11 (0.50) | KIF11ARPDPK1HDAC1HDAC6 | |
| SCHEMBL21116533 | 0.85 | KIF11 (0.45) | KIF11TRPV4ARPDPK1PTPN5 | |
| SCHEMBL21116555 | 0.84 | KIF11 (0.56) | KIF11TRPV4ARPGRCYP11B2 | |
| SCHEMBL21116553 | 0.83 | KIF11 (0.40) | KIF11ARPGRPDPK1SCN9A | |
| SCHEMBL23798840 | 0.82 | AR (0.39) | KIF11ARPGRKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| EP-3478656-B1 | DICARBAZOLE DIPHENYL DERIVATIVES FOR USE IN OPTOPELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-09-08 | — | — | EP | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | KIF11 3544/4885TRPV4 1331/4885AR 1096/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | KIF11 3520/4885TRPV4 1631/4885AR 1080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.